ArticleDiagnostics (Basel, Switzerland)2023

Restricted Mean Survival Time-Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors?

Cristina-Florina Pîrlog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.